Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 vaccine are important to drive future vaccination strategies. Yet, available literature is scarce. Covidiagnostix is a multicenter study designed to assess the antibody response in >1000 healthcare...
Main Authors: | Davide Ferrari, Nicola Clementi, Elena Criscuolo, Alessandro Ambrosi, Francesca Corea, Chiara Di Resta, Rossella Tomaiuolo, Nicasio Mancini, Massimo Locatelli, Mario Plebani, Giuseppe Banfi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/11/1357 |
Similar Items
-
Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers
by: Cristina Costa, et al.
Published: (2022-03-01) -
Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination
by: Jolanta Kiewisz, et al.
Published: (2022-04-01) -
A Case of Atypical Unilateral Optic Neuritis Following BNT162b2 mRNA COVID-19 Vaccination
by: Shuntaro Motegi, et al.
Published: (2022-09-01) -
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
by: Elizabeth K. Graydon, et al.
Published: (2023-08-01) -
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
by: Ariel Israel, et al.
Published: (2021-12-01)